Anavex Life Sciences to Present at the H C Wainwright 4th Annual Neuropsychiatry Virtual Conference forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Health Canada Special Access Program (SAP) Authorizes ANAVEX®2-73 (blarcamesine) for patients after successful completion of Open-Label Extension (OLE) study Granting of requests are also ongoing in United Kingdom
Health Canada Special Access Program Authorizes ANAVEX®2-73 for patients after successful completion of Open-Label Extension study Granting of requests are also ongoing in United Kingdom and. | June 15, 2023
NEW YORK, June 01, 2023 Anavex Life Sciences Corp. , a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and. | June 1, 2023
02.05.2023 - Webcast and Conference Call To be Held Tuesday, May 9, 2023, 8:30 am ETNEW YORK, May 02, 2023 (GLOBE NEWSWIRE) - Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing .